OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
April 03, 2024
Advanced oral dosage forms allow for modulation of controlled- and sustained-release profiles.
March 03, 2024
Activation and expansion are essential for success in both autologous and allogeneic therapies.
February 03, 2024
Continuous manufacturing and a quality-by-design development approach are a natural fit.
January 03, 2024
Buffers, stabilizers, and cryoprotectants play major roles in cell therapy formulations.
December 03, 2023
Matching excipients to API properties is essential.
November 03, 2023
Predictive modeling facilitates the identification of coformers, cocrystal components, and complexing agents.